Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319485 · ClinicalTrials.gov registry record · NA
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease
A NA study of Parkinson Disease, sponsored by InSightec.
- Active
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 20
- Study locations
NCT03319485 is a NA study of Parkinson Disease that is active but no longer recruiting, run by InSightec. The registered enrollment target is 92 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT03319485, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by InSightec.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 20
- Study locations
Study Summary
Evaluate the safety and efficacy of unilateral focused ultrasound pallidotomy using the ExAblate 4000 System in the management of dyskinesia symptoms or motor fluctuations for medication refractory, advanced idiopathic Parkinson's disease.
Conditions Studied
Interventions
- DEVICE ExAblate Pallidotomy
- DEVICE Sham ExAblate Pallidotomy
Study Locations (20)
Other
- Rambam Health Care - Haifa
- Fondazione IRCCS Neurological Institute Carlo Besta - Milan
- Azienda Ospedaliera Universitaria di Verona, Univerista di Verona - Verona
- Severance Hospital, Yonsei University Health System - Seoul
- Chang Bing Show Chwan Memorial Hospital - Changhua
- St. Mary's Hospital - London
New York
- New York University Health Langone - New York
- Weill Cornell Medicine - New York
California
- Stanford University Medical Center - Stanford
Florida
- Palm Beach Neuroscience Institute/Sperling Medical Group - Boynton Beach
Maryland
- University of Maryland Medical System - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- The Ohio State Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319485
The ClinicalTrials.gov registry entry for NCT03319485 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which ExAblate Pallidotomy is the first listed.
NCT03319485 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT03319485 about?
NCT03319485 is a clinical study titled "ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease". Evaluate the safety and efficacy of unilateral focused ultrasound pallidotomy using the ExAblate 4000 System in the management of dyskinesia symptoms or motor fluctuations for medication refractory, advanced idiopathic Parkinson's disease.
What is the current status of trial NCT03319485?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2018-02-09. Estimated completion is 2026-08-31.
What conditions does trial NCT03319485 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT03319485?
The interventions under investigation include: ExAblate Pallidotomy (DEVICE), Sham ExAblate Pallidotomy (DEVICE).
Who is sponsoring clinical trial NCT03319485?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03319485 being conducted?
This trial has 20 study locations across California, Florida, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.